ShareValue scores for NIVF: Valuation 58, Quality 54, Growth 43, Health 47.

NewGenIvf Group Limited Class A Ordinary Shares logo

NIVF
NASDAQ

NewGenIvf Group Limited Class A Ordinary Shares

$0.57(-8.17%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 16%
Valuation
58
Fair Value
Price vs Value
Quality
54
Moderate
Business Strength
Growth
43
Moderate
Revenue & Earnings
Health
47
Moderate
Financial Stability
Momentum
59
Neutral
Price Trend

Company Details

About

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026